Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LILRB5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SMCR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MAP3K10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF843 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRTAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C4orf46 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100130468 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRNA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLMAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC1A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IMPA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on